Holding Fast (HBR Case Study and Commentary)  

Oleh:

Gourville, John T. ; Lutz, Robert A. ; Christensen, Clayton M. ; Wittes, Jason ; Galakatos, Nick

Jenis: Article from Bulletin/Magazine - ilmiah internasional
Dalam koleksi: Harvard Business Review bisa di lihat di link (http://web.b.ebscohost.com/ehost/command/detail?sid=f227f0b4-7315-44a4-a7f7-a7cd8cbad80b%40sessionmgr114&vid=12&hid=105&bdata=JnNpdGU9ZWhvc3QtbGl2ZQ%3d%3d#db=bth&jid=HBR) vol. 83 no. 6 (Jun. 2005), page 35-47.
Topik: holding period; acquisitions; brand management; disruptive technologies; HBR case discussions; innovation; product development; risk assessment

Ketersediaan

Perpustakaan Pusat (Semanggi) Nomor Panggil: HH10.28 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

CEO Peter Walsh faces a classic innovator's dilemma. His company, Crescordia, produces high - quality metal plates, pins, and screws that orthopedic surgeons use to repair broken bones. In fact, because of the company's long-standing commitment to quality, some orthopedic surgeons use nothing but Crescordia hardware. And now these customers have begun to clamor for the next - generation technology : resorbable hardware. Resorbables offer clear advantages over the traditional hardware. Like dissolving sutures, resorbable plates and screws are made of biodegradable polymers. They hold up long enough to support a healing bone, then gradually and harmlessly disintegrate in the patient's body. The new products, however, are not yet reliable; they fail about 8 % of the time. That's why Crescordia has delayed launching a line using the new technology. But time is running out. A few competitors have begun to sell resorbables, despite their imperfections, and these companies are picking up market share. Should Crescordia join the fray and risk tarnishing its brand ? Or should the company sit tight until it can offer a perfect product ? Commenting on this fictional case study in R0506A and R0506Z are Robert A. Lutz, vice - chairman of product development at General Motors; Clayton M. Christensen, the Robert and Jane Cizik Professor of Business Administration at Harvard Business School ; Jason Wittes, a senior equity analyst covering medical supplies and devices at Leerink Swann ; and Nick Galakatos, a general partner of MPM Capital.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali